OncoCyte's total assets for Q3 2024 were $70.22M, a decrease of -6.03% from the previous quarter. OCX total liabilities were $60.51M for the fiscal quarter, a 16.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.